Non-Hodgkin lymphoma

New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS.

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.

A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.

A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent’s antibody drug for non-Hodgkin lymphoma.